Eli Lilly and Company (LLY) — closed signal from April 18, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on July 17, 2026.
Predicted vs. what happened
LLY price · publication thesis → realized outcomesplit-adjusted
$905.00 – $925.00Entry zone — fair-value band
$927.03Published — price the day we called it
$1,084.63Target — the price the thesis aimed for
$1,249.45Peak — highest point inside the window, not a realized return
$1,179.11Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 39 days.
Peak price
$1,249.45
peak on July 7, 2026 — not a realized returnPeak gain
+34.8%
peak, from the publication priceWindow close
$1,179.11
end-of-window price, context onlyDays to target
39
Window
April 18, 2026 – July 17, 2026
The thesis — published April 18, 2026
Predicted growth
+17%
over the measurement windowTarget price
$1,084.63
the price the thesis aimed forEntry zone
$905.00 – $925.00
the fair-value band we waited forPrice at publication
$927.03
published April 18, 2026Confidence
85%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Eli Lilly has steady business momentum and reliable execution, and recent updates on the Foundayo treatment keep attention on its diabetes and obesity products. The stock isn't as overextended as many fast growers, so the situation looks reasonably balanced: some protection in weak markets, clear near-term news to watch, and solid earnings quality for the coming quarter.
Primary drivers
- Foundayo safety and filing plans create near-term news potential
- Diabetes and obesity drugs keep revenue growth steady
- Stock sits nearer trend support than many high-growth peers
- Ongoing positive newsflow reinforces product leadership story
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.